Overview
  • ShareThis
  • Print
  • Text Size

Partnering with MannKind

We are dedicated to bringing innovative therapies to patients and their caregivers, and partnering is at the core of our organization’s business strategy.

We are focused on establishing partnerships to build therapeutic programs of significant clinical and commercial value by:

  • Enhancing and expanding our pipeline of innovative product candidates for both diabetes and oncology
  • Applying our novel Technosphere®, DreamboatTM & CricketTM technologies and services to support partner development efforts for their own proprietary programs and compounds.

Whether through strategic alliances, licensing arrangements and/or research collaborations, our partnering approach is based on a flexible, creative methodology designed to establish mutually beneficial relationships that are positioned to capture upside potential beyond what either partner could achieve individually.

The MannKind team would be delighted to speak with you. To discuss partnership opportunities, please contact:

Jonathan Goldman
Business Development

(201) 983-5109
jgoldman@mannkindcorp.com

We welcome the opportunity to work with other organizations in order to build products of exceptional value to patients, strategic partners and investors.

Hakan Edstrom
COO, MannKind